GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,394.50p
   
  • Change Today:
      32.00p
  • 52 Week High: 1,788.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,103.57m
  • Volume: 9,852,850
  • Market Cap: £57,224m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

London close: Stocks finish choppy week in the black

By Josh White

Date: Friday 16 May 2025

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.

GSK Regulatory News

Transaction in Own Shares 16-May-2025 07:00 RNS
Transaction in Own Shares 15-May-2025 07:00 RNS
GSK to acquire efimosfermin 14-May-2025 07:00 RNS
Transaction in Own Shares 14-May-2025 07:00 RNS
Director/PDMR Shareholding 13-May-2025 15:30 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,394.50p
Change Today 32.00p
% Change 2.35 %
52 Week High 1,788.50p
52 Week Low 1,264.00p
Volume 9,852,850
Shares Issued 4,103.57m
Market Cap £57,224m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.15% below the market average38.15% below the market average38.15% below the market average38.15% below the market average38.15% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Price Trend
4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average
40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average
Income
76.29% above the market average76.29% above the market average76.29% above the market average76.29% above the market average76.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average39.08% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 16-May-2025

Time Volume / Share Price
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p
16:20 0 @ 1,397.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page